These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 10480509)

  • 1. Antibodies to GAD65 and a tyrosine phosphatase-like molecule IA-2ic in Filipino type 1 diabetic patients.
    Medici F; Hawa MI; Giorgini A; Panelo A; Solfelix CM; Leslie RD; Pozzilli P
    Diabetes Care; 1999 Sep; 22(9):1458-61. PubMed ID: 10480509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of antibodies to islet protein tyrosine phosphatase-like molecule in predicting type 1 diabetes.
    Hawa M; Rowe R; Lan MS; Notkins AL; Pozzilli P; Christie MR; Leslie RD
    Diabetes; 1997 Aug; 46(8):1270-5. PubMed ID: 9231650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel fusion proteins in the analysis of diabetes-associated autoantibodies to GAD65 and IA-2.
    Zavialov A; Ankelo M; Westerlund-Karlsson A; Knip M; Ilonen J; Hinkkanen A
    J Immunol Methods; 2000 Dec; 246(1-2):91-6. PubMed ID: 11121550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The combination of antibodies to GAD-65 and IA-2ic can replace the islet-cell antibody assay to identify subjects at risk of type 1 diabetes mellitus.
    Hatziagelaki E; Jaeger C; Petzoldt R; Seissler J; Scherbaum WA; Federlin K; Bretzel RG
    Horm Metab Res; 1999 Oct; 31(10):564-9. PubMed ID: 10596966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM. The DENIS Study Group. Deutsche Nikotinamid Interventions-Studie.
    Seissler J; Morgenthaler NG; Achenbach P; Lampeter EF; Glawe D; Payton M; Christie M; Scherbaum WA
    Diabetologia; 1996 Nov; 39(11):1351-6. PubMed ID: 8933004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of avidity maturation of autoantibodies to the protein tyrosine phosphatase-like IA-2 molecule and glutamic acid decarboxylase (GAD65) during progression to type 1 diabetes.
    Westerlund A; Ankelo M; Ilonen J; Knip M; Simell O; Hinkkanen AE
    J Autoimmun; 2005 Mar; 24(2):153-67. PubMed ID: 15829408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitive non-isotopic assays for autoantibodies to IA-2 and to a combination of both IA-2 and GAD65.
    Chen S; Willis J; Maclean C; Ananieva-Jordanova R; Amoroso MA; Brooking H; Powell M; Collins A; Bennett S; Mitchell S; Burne P; Furmaniak J; Smith BR
    Clin Chim Acta; 2005 Jul; 357(1):74-83. PubMed ID: 15963796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrosine phosphatase-like protein (IA-2) and glutamic acid decarboxylase (GAD65) autoantibodies: a study of Chinese patients with diabetes mellitus.
    Ng WY; Lee YS; Todd AL; Lui KF; Loke KY; Thai AC
    Autoimmunity; 2002 Mar; 35(2):119-24. PubMed ID: 12073931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct IA-2 autoantibody epitope recognition between childhood-onset and adult-onset type 1 diabetes.
    Kawasaki E; Sera Y; Abiru N; Yamauchi M; Ozaki M; Yamakawa K; Abe T; Uotani S; Yamasaki H; Yamaguchi Y; Eguchi K
    Ann N Y Acad Sci; 2002 Apr; 958():235-40. PubMed ID: 12021114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutamic acid decarboxylase and ICA512/IA-2 autoantibodies as disease markers and relationship to residual beta-cell function and glycemic control in young type 1 diabetic patients.
    Zanone MM; Catalfamo E; Pietropaolo SL; Rabbone I; Sacchetti C; Cerutti F; Trucco M; Cavallo-Perin P
    Metabolism; 2003 Jan; 52(1):25-9. PubMed ID: 12524658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of antibody responses to endogenous and exogenous antigen in the nonobese diabetic mouse.
    Koczwara K; Schenker M; Schmid S; Kredel K; Ziegler AG; Bonifacio E
    Clin Immunol; 2003 Feb; 106(2):155-62. PubMed ID: 12672406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Glutamic acid decarboxylase and tyrosine phosphatase-like IA-2 antibodies for diabetes classification in unselected diabetic patients].
    Reinsch B; Zimmy S; Schatz H; Pfohl M
    Med Klin (Munich); 2003 Feb; 98(2):67-71. PubMed ID: 12601530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Islet autoantibodies in Latvian subjects with non-insulin-dependent diabetes mellitus: slow-onset type 1 diabetes or polyendocrine autoimmunity?
    Shtauvere-Brameus A; Falorni A; Rumba I; Sanjeevi CB
    Ann N Y Acad Sci; 2002 Apr; 958():259-62. PubMed ID: 12021119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of autoantibodies to ICA512 and GAD in the sera of patients with diabetic ketoacidosis or ketonemia].
    Zhang YJ; Chen HL; Yu LP; Han XY
    Hunan Yi Ke Da Xue Xue Bao; 2000 Dec; 25(6):545-7. PubMed ID: 12516400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between IA-2 autoantibody epitope specificities and age of onset in Japanese patients with autoimmune diabetes.
    Kawasaki E; Sera Y; Fujita N; Yamauchi M; Ozaki M; Abe T; Yamakawa K; Uotani S; Takino H; Yamasaki H; Yamaguchi Y; Uchigata Y; Matsuura N; Eguchi K
    J Autoimmun; 2001 Dec; 17(4):323-31. PubMed ID: 11771957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [IA-2 and anti-GAD antibodies in patients with newly diagnosed type 1 diabetes and their first degree relatives].
    Kretowski A; Kowalska I; Peczyńska J; Urban M; Kinalska I
    Przegl Lek; 2000; 57(3):143-6. PubMed ID: 10909282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological heterogeneity in type I diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease.
    Seissler J; de Sonnaville JJ; Morgenthaler NG; Steinbrenner H; Glawe D; Khoo-Morgenthaler UY; Lan MS; Notkins AL; Heine RJ; Scherbaum WA
    Diabetologia; 1998 Aug; 41(8):891-7. PubMed ID: 9726590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the efficacy of the combination of multiple autoantibodies to islet-specific antigens in Korean type 1 diabetic patients.
    Park Y; Lee H; Takino H; Abiru N; Kawasaki E; Eisenbarth GS
    Acta Diabetol; 2001; 38(1):51-6. PubMed ID: 11487177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral immunity against glutamic acid decarboxylase and tyrosine phosphatase IA-2 in Lambert-Eaton myasthenic syndrome.
    Hermitte L; Martin-Moutot N; Boucraut J; Barone R; Atlan-Gepner C; Seagar M; Pouget J; Kleisbauer JP; Couraud F; Vialettes B
    J Clin Immunol; 2000 Jul; 20(4):287-93. PubMed ID: 10939716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic and immune parameters at clinical onset of insulin-dependent diabetes: a population-based study. IMDIAB Study Group. Immunotherapy Diabetes.
    Pozzilli P; Visalli N; Buzzetti R; Cavallo MG; Marietti G; Hawa M; Leslie RD
    Metabolism; 1998 Oct; 47(10):1205-10. PubMed ID: 9781622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.